| PERIOD ENDING | 28-Mar-09 | 31-Dec-08 | 27-Sep-08 | 28-Jun-08 | | Total Revenue | 98,913 | 188,453 | 250,098 | 257,740 | | Cost of Revenue | 73,175 | 119,936 | 138,574 | 146,777 | | | Gross Profit | 25,738 | 68,517 | 111,524 | 110,963 | | | Operating Expenses | | Research Development | 36,015 | 50,856 | 51,649 | 59,815 | | Selling General and Administrative | 43,102 | 47,516 | 53,858 | 62,530 | | Non Recurring |
-
| 104,067 |
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (53,379) | (133,922) | 6,017 | (11,382) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 1,296 | 2,861 | 3,055 | 4,916 | | Earnings Before Interest And Taxes | (52,083) | (131,061) | 9,072 | (6,466) | | Interest Expense |
-
| 7,021 |
-
|
-
| | Income Before Tax | (52,083) | (138,082) | 9,072 | (6,466) | | Income Tax Expense | 14,309 | (7,831) | 7,675 | (4,081) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (66,392) | (130,251) | 1,397 | (2,385) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (66,392) | (130,251) | 1,397 | (2,385) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($66,392) | ($130,251) | $1,397 | ($2,385) |
|
0.45% Nasdaq 
0.20%
Income Statement
